ATON Overview

  • Year Founded
  • 1998

Year Founded

  • Status
  • Public

  • Employees
  • 9

Employees

  • Stock Symbol
  • ALTAO

Stock Symbol

  • Investments
  • 3

ATON General Information

Description

Aton is a biopharmaceutical company that foresees a focused future of medicine. The company specializes in the main businesses: Inoviem Scienfic and B Cell Design. The company's services include pre-clinical and Clinical Services, Monoclonal Antibodies Production, Laboratory equipment Production, and Human Tissue Provision.

Contact Information

Formerly Known As
Hybrigenics
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 850 Boulevard Sébastien Brant
  • 67400 Illkirch-Graffenstaden
  • France
+33 09
Primary Industry
Drug Discovery
Stock Exchange
PAR
Vertical(s)
Corporate Office
  • 850 Boulevard Sébastien Brant
  • 67400 Illkirch-Graffenstaden
  • France
+33 09

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ATON Stock Performance

As of 20-Nov-2026, ATON’s current market cap is $6.93M with 1.13B shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$6.93M 1.13B 23.7M

ATON Financials Summary

As of 30-Jun-2026, ATON has a trailing 12-month revenue of $700K.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 19,338 12,235 13,927 13,623
Revenue 700 746 664 662
EBITDA (327) (117) (691) (775)
Net Income (1,121) (1,085) (1,191) (8,515)
Total Assets 6,457 6,821 6,713 10,790
Total Debt 4,708 5,816 4,843 7,603
Public Fundamental Data provided by Morningstar, Inc. disclaimer

ATON Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore ATON‘s full profile, request access.

Request a free trial

ATON Patents

ATON Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2020120644-A1 New anti tau svqivykpv epitope single domain antibody Inactive 13-Dec-2018
EP-3487506-A1 Combinations of inecalcitol with an anti-cd38 agent and their uses for treating cancer Inactive 20-Jul-2016
US-10478497-B2 Combinations of inecalcitol with an anti-cd38 agent and their uses for treating cancer Active 20-Jul-2016
US-20180021432-A1 Combinations of inecalcitol with an anti-cd38 agent and their uses for treating cancer Active 20-Jul-2016
WO-2018015498-A1 Combinations of inecalcitol with an anti-cd38 agent and their uses for treating cancer Inactive 20-Jul-2016 A61K39/39558
To view ATON’s complete patent history, request access »

ATON Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ATON Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore ATON‘s full profile, request access.

Request a free trial

ATON Acquisitions (3)

ATON’s most recent deal was a Merger/Acquisition with Imaxio (Genomics Unit). The deal was made on 11-Oct-2013.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Imaxio (Genomics Unit) 11-Oct-2013 Merger/Acquisition Other Healthcare Services
Dualsystems Biotech (Y2H Activities) 01-Jul-2013 Merger/Acquisition Other Healthcare Services
Semaia Pharmaceuticals 29-Apr-2003 Merger/Acquisition Drug Discovery
To view ATON’s complete acquisitions history, request access »

ATON ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view ATON’s complete esg history, request access »

ATON FAQs

  • When was ATON founded?

    ATON was founded in 1998.

  • Where is ATON headquartered?

    ATON is headquartered in Illkirch-Graffenstaden, France.

  • What is the size of ATON?

    ATON has 9 total employees.

  • What industry is ATON in?

    ATON’s primary industry is Drug Discovery.

  • Is ATON a private or public company?

    ATON is a Public company.

  • What is ATON’s stock symbol?

    The ticker symbol for ATON is ALTAO.

  • What is the current market cap of ATON?

    The current market capitalization of ATON is $6.93M.

  • What is ATON’s current revenue?

    The trailing twelve month revenue for ATON is $700K.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process